For research use only. Not for therapeutic Use.
Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1].
| Catalog Number | I043777 |
| CAS Number | 1578199-75-3 |
| Purity | ≥95% |
| Reference | [1]. Yvette N Lamb. Galcanezumab: First Global Approval. Drugs. 2018 Nov;78(16):1769-1775. |
